Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00006496 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Molecular Epidemiology of Acute Respiratory Distress Syndrome (ARDS)

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Aug 2026 → Aug 2028
See other at-risk trials from Massachusetts General Hospital

Record History

  1. Primary completion pushed from Aug 2026 to Aug 2028 Completion pushed from Dec 2026 to Dec 2028 · Eligibility criteria expanded, about 6 words · Publications: details revised at 3 of 3 entries Show 3 more changesShow less
    • Completion pushed from Dec 2026 to Dec 2028
    • Eligibility criteria expanded, about 6 words
    • Publications: details revised at 3 of 3 entries
  2. Primary completion date: Aug 2023 to Aug 2026 Completion date: Dec 2023 to Dec 2026 · Study title expanded, about 4 wordsv10 Show 2 more changesShow less
    • Completion date: Dec 2023 to Dec 2026
    • Study title expanded, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  3. Primary completion date: Aug 2022 to Aug 2023 Completion date: Dec 2022 to Dec 2023v9 Show 1 more changeShow less
    • Completion date: Dec 2022 to Dec 2023
  4. Trial status: Recruiting to Active, Not Recruiting Site details revisedv8 Show 1 more changeShow less
    • Site details revised
  5. Primary completion date: Aug 2019 to Aug 2022 Completion date: Dec 2019 to Dec 2022v7 Show 1 more changeShow less
    • Completion date: Dec 2019 to Dec 2022
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Aug 2017 to Aug 2019 Completion date: Dec 2017 to Dec 2019v6 Show 1 more changeShow less
    • Completion date: Dec 2017 to Dec 2019
  2. Primary completion date: Mar 2016 to Aug 2017 Completion date: Mar 2016 to Dec 2017 · Eligibility criteria expanded, about 65 wordsv5 Show 2 more changesShow less
    • Completion date: Mar 2016 to Dec 2017
    • Eligibility criteria expanded, about 65 words

    See this version in full on ClinicalTrials.gov ↗

  3. Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI) to Massachusetts General Hospital Primary and study completion dates: Dec 2005 to Mar 2016 · Trial status: Completed to Recruiting · Enrollment target: 4000 · 3 morev4 Show 6 more changesShow less
    • Primary and study completion dates: Dec 2005 to Mar 2016
    • Trial status: Completed to Recruiting
    • Enrollment target: 4000
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 11 words
    • Collaborators expanded, about 7 words

    See this version in full on ClinicalTrials.gov ↗

  4. Trial status: Active, Not Recruiting to Completed Primary completion date: Dec 2005v3 Show 1 more changeShow less
    • Primary completion date: Dec 2005
  5. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To examine the possible relationship between genetic factors and the acute respiratory distress syndrome (ARDS).
Trial Details
NCT Number NCT00006496
Lead Sponsor Massachusetts General Hospital
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Acute Respiratory Distress Syndrome, Lung Diseases
Enrollment 4,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov